OR WAIT null SECS
November 13, 2014
The agency cites deviations from CGMPs for the manufacture of APIs at the company?s Gujarat, India plant.
October 03, 2014
Impurities, particulates, and a lack of communication are among Hospira's recent violations described in a warning letter from FDA.
September 25, 2014
Meeting increasing expectations and escalating regulatory requirements to protect patients.
August 20, 2014
FDA found violations of cGMP at finished-drug manufacturer in India.
July 16, 2014
Trifarma cited for significant deviations in data collection and security, and employee training.
June 26, 2014
GSK Biologicals receives warning about cGMP compliance issues at its Quebec facility.
June 18, 2014
FDA cites cGMP violations for API manufacturing at a facility in Tianjin, China.
FDA inspection found cGMP violations in the Bangalore, India API manufacturing facility.
June 04, 2014
The Rx360 pharmaceutical supply chain consortium celebrated its first five years with an anniversary conference the week of June 5, 2014 in Washington, D.C. The conference featured key FDA officials and industry leaders.
April 30, 2014
Allergy Therapeutics announced that its Worthing facility has received its Certificate of GMP Compliance following recent inspection by the MHRA.